Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. 2007

Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.

Nicotinic systems have been found in a variety of studies to play important roles in cognitive function. Nicotinic involvement in different aspects of cognitive function such as learning vs. memory may differ. We have found in rats that the spatial repeated acquisition task in the radial-arm maze is significantly improved by low doses of the nicotinic receptor antagonist mecamylamine, the atypical nicotinic receptor ligand lobeline, as well as the alpha7 nicotinic receptor agonist ARR-17779. Interestingly, nicotine in the same dose range that improves working memory in the win-shift radial maze task was not effective in improving repeated acquisition performance. Nicotinic systems interact with a variety of other neural systems. Differential involvement of these extended effects with learning vs. memory may help explain differential effects of nicotinic drugs with these cognitive functions. Histamine H(3) receptor antagonists have been shown by some studies to improve cognitive function, but others have not found this effect and some have found impairment. Nicotine stimulates the release of histamine. This effect may counter other cascading effects of nicotine in the performance of learning and memory tasks. A specific test of this hypothesis involves our study of nicotine (0.1-0.4 mg/kg) interactions with the histamine H(3) receptor antagonist thioperamide (2.5-10 mg/kg) on learning memory in the repeated acquisition test in the radial-arm maze. The highest dose of thioperamide tested caused a significant choice accuracy impairment, which was most evident during the later portions of the learning curve. The highest dose of nicotine did not change overall errors but did cause a significant impairment in learning over trials. The choice accuracy impairment induced by thioperamide was significantly attenuated by nicotine (0.4 mg/kg). The learning impairment caused by the highest dose of nicotine was significantly attenuated by thioperamide. Thioperamide also caused a slowing of response, an effect, which was attenuated by nicotine co-administration. The repeated acquisition test can help differentiate acute drug effects on learning. Nicotine and thioperamide effectively reversed each other's choice accuracy impairment even though each by itself impaired accuracy.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D010880 Piperidines A family of hexahydropyridines.
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D012054 Reinforcement, Psychology The strengthening of a conditioned response. Negative Reinforcement,Positive Reinforcement,Psychological Reinforcement,Reinforcement (Psychology),Negative Reinforcements,Positive Reinforcements,Psychological Reinforcements,Psychology Reinforcement,Psychology Reinforcements,Reinforcement, Negative,Reinforcement, Positive,Reinforcement, Psychological,Reinforcements (Psychology),Reinforcements, Negative,Reinforcements, Positive,Reinforcements, Psychological,Reinforcements, Psychology
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine

Related Publications

Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
January 1992, Neurotoxicology,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
March 1988, Journal of the experimental analysis of behavior,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
July 2006, Neurobiology of learning and memory,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
January 1986, Psychopharmacology,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
May 2011, Neurobiology of learning and memory,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
July 1989, Behavioral and neural biology,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
January 1988, Neurotoxicology,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
July 1991, Brain research bulletin,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
November 1983, Behavioral and neural biology,
Ehsan Kholdebarin, and D Patrick Caldwell, and W Paul Blackwelder, and Margaret Kao, and N Channelle Christopher, and Edward D Levin
April 1997, Journal of experimental psychology. Animal behavior processes,
Copied contents to your clipboard!